Abstract
Clinical studies of the treatment of glioma and cutaneous melanoma using boron neutron capture therapy (BNCT) are currently taking place in the USA, Europe and Japan. New BNCT clinical facilities are under construction in Finland, Sweden, England and California. The observation of transient acute effects in the oral mucosa of a number of glioma patients involved in the American clinical trials, suggests that radiation damage of the oral mucosa could be a potential complication in future BNCT clinical protocols, involving higher doses and larger irradiation field sizes. The present investigation is the first to use a high resolution surface analytical technique to relate the microdistribution of boron-10 (10B) in the oral mucosa to the biological effectiveness of the 10B(n,α)7Li neutron capture reaction in this tissue. The two boron delivery agents used clinically in Europe/Japan and the USA, borocaptate sodium (BSH) and p-boronophenylalanine (BPA), respectively, were evaluated using a rat ventral tongue model. 10B concentrations in various regions of the tongue mucosa were estimated using ion microscopy. In the epithelium, levels of 10B were appreciably lower after the administration of BSH than was the case after BPA. The epithelium:blood 10B partition ratios were 0.2:1 and 1:1 for BSH and BPA respectively. The 10B content of the lamina propria was higher than that measured in the epithelium for both BSH and BPA. The difference was most marked for BSH, where 10B levels were a factor of six higher in the lamina propria than in the epithelium. The concentration of 10B was also measured in blood vessel walls where relatively low levels of accumulation of BSH, as compared with BPA, was demonstrated in blood vessel endothelial cells and muscle. Vessel wall:blood 10B partition ratios were 0.3:1 and 0.9:1 for BSH and BPA respectively. Evaluation of tongue mucosal response (ulceration) to BNC irradiation indicated a considerably reduced radiation sensitivity using BSH as the boron delivery agent relative to BPA. The compound biological effectiveness (CBE) factor for BSH was estimated at 0.29 ± 0.02. This compares with a previously published CBE factor for BPA of 4.87 ± 0.16. It was concluded that variations in the microdistribution profile of 10B, using the two boron delivery agents, had a significant effect on the response of oral mucosa to BNC irradiation. From a clinical perspective, based on the findings of the present study, it is probable that potential radiation-induced oral mucositis will be restricted to BNCT protocols involving BPA. However, a thorough high resolution analysis of 10B microdistribution in human oral mucosal tissue, using a technique such as ion microscopy, is a prerequisite for the use of experimentally derived CBE factors in clinical BNCT. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ang KK, Landuyt W, Rijners A and Schueren and van der E (1984) Differences in repopulation kinetics in mouse skin during split course multiple fractions per day (MDF) or daily fractionated irradiations. Int J Radiat Oncol Biol Phys 10: 95–99
Archambeau JO (1989) A model to evaluate dose recovery from different radiation. Clinical Aspects of Neutron Capture Therapy, 9–20, Plenum Press: New York
Ausserer WA, Ling YC, Chandra S and Morrison GH (1989) Quantitative imaging of boron, calcium, magnesium, potassium and sodium distributions in cultured cells with ion microscopy. Anal Chem 61: 2690–2695
Barth RF, Adams DM, Soloway AH, Mechetner EB, Alam F and Anisuzzaman AKM (1991) Determination of boron in tissues and cells using direct current plasma atomic emission spectroscopy. Anal Chem 63: 890–893
Barth RF, Soloway AH, Goodman JH, Gahbauer RA, Gupta N, Blue TE, Yang W and Tjarks W (1999) Boron neutron capture therapy of brain tumours: an emerging therapeutic modality. Neurosurgery 44: 433–451
Benninghoven A, Rudenauer FG and Werner HW (1987) Instrumentation. Elving PJ, Eincfordner JD, Kolthoff IMSecondary ion mass spectrometry, basic concepts, instrumental aspects, applications and trends, 594–606, John Wiley & Sons: New York
Coderre JA and Morris GM (1999) The radiation biology of boron neutron capture therapy. Radiat Res 151: 1–18
Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM and Liu HB (1994) Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine–fructose complex. Int J Radiat Oncol Biol Phys 30: 643–652
Coderre JA, Bergland R, Capala J, Chadha M, Chanana AD, Elowitz E, Joel DD, Liu HB and Slatkin DN (1997) Boron neutron capture therapy for glioblastoma multiform using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J Neuro-oncol 33: 141–152
Coderre JA, Morris GM, Micca PL, Ma RM and Gordon CR (1999) The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model. Radiat Res 152: 113–118
Dorr W and Kummermehr J (1990) Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol 17: 249–259
Dutreix J, Tubiana M, Wambersie A and Malaise E (1971) The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Eur J Cancer 7: 205–213
Fairchild RG, Gabel D, Laster BH, Greenberg D, Kiszenick W and Micca PL (1986) Microanalytical techniques for boron analysis using the 10B(n,α)7Li reaction. Med Phys 13: 50–56
Feldman LC and Mayer JW (1986) Radiative transitions and the electron microprobe. Fundamentals of Surface and Thin Film Analysis, 243–247, North Holland: New York
Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M and Mishima Y (1994) Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the skin. Radiat Res 138: 435–442
Gabel D, Holstein H, Laarsson B, Gille L, Ericson G, Sacker D, Som P and Fairchild RG (1987 a) Quantitative neutron capture radiography for studying the biodistribution of tumour-seeking boron-containing compounds. Cancer Res 47: 5451–5454
Gabel D, Foster S and Fairchild RG (1987 b) The Monte Carlo simulation of the biological effect of the 10B(n,α)7Li reaction in cells and tissue and its implications for boron neutron capture therapy. Radiat Res 111: 14–25
Gavin PR, Kraft SL, Huiskamp R and Coderre JA (1997) A review: CNS effects and normal tissue tolerance in dogs. J Neuro-Oncol 33: 71–80
Hatanaka H and Nakagawa Y (1994) Clinical results of long-surviving brain tumour patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28: 61–66
Hiratsuka J, Fukuda H, Kobayashi T, Karashima H, Yoshino K, Imajo Y and Mishima Y (1991) The relative biological effectiveness of 10B neutron capture therapy for early skin reactions in the hamster. Radiat Res 128: 186–191
Imahori Y, Ucda Y, Ohmori T, Kusuki T, Ono K, Fujii R and Ido T (1998) Fluorine-18 labelled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39: 325–333
Joel DD, Fairchild RG, Laissue JA, Saraf SK, Kalef-Ezra JA and Slatkin DN (1990) Boron neutron capture therapy for intracerebral rat gliosarcomas. Proc Natl Acad Sci USA 87: 9808–9812
Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CPD, Roberts TG, Reddy NK, Buonocore E and Hubner KFC (1997) Evaluation of fluorine-18 BPA fructose for boron neutron capture treatment planning. J Nucl Med 38: 1762–1767
Kobayashi T and Kanda K (1982) Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy. Radiat Res 91: 77–94
Morris GM, Coderre JA, Hopewell JW, Micca PL and Rezvani M (1994) Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium. Radiother Oncol 39: 253–259
Morris GM, Coderre JA, Smith DR and Hopewell JW (1999) A rat model of oral mucosal response to boron neutron capture irradiation. Proceedings of the Eighth International Symposium on Neutron Capture therapy for Cancer, Plenum Press: New York
Moses R and Kummermehr J (1986) Radiation response of the mouse tongue epithelium. Brit J Cancer 53 Suppl VII: 12–15
Parkins C, Fowler JF and Shen Y (1983) A murine model of lip epidermal/mucosal reactions to x-irradiation. Radiother Oncol 1: 159–165
Smith DR, Chandra S, Coderre JA and Morrison GH (1996) Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumour model for boron neutron capture therapy. Cancer Res 56: 4302–4306
Smith DR, Chandra S, Coderre JA, Barth RF, Yang W, Liu L, Wilson JL, Micca PL, Nawrocky MM, Rotaru JH and Morrison GH (1997) Quantitative ion microscopy imaging of boron-10 in rat brain tumour models for BNCT. Advances in Neutron Capture Therapy, Chemistry and Biology II, Larson B, Crawford J, Weinreich R308–314, Elsevier Science: Amsterdam
van der Schueren E, van der Bogaert W and Ang KK (1983) Radiotherapy with multiple fractions per day. The Biological Basis of Radiotherapy, Steel GG, Adams G, Peckam M195–210, Elsevier Science: Amsterdam
Verrijk R, Huiskamp R, Begg AC, Wheeler FJ and Watkins PRD (1994) A comprehensive PC based computer model for microdosimetry of BNCT. Int J Radiat Biol 65: 241–253
Yamamoto YL (1961) The biological effectiveness of thermal neutrons and of the heavy particles from the 10B(n,α)7Li reaction for the rabbits ear and its utilisation for neutron capture therapy. Yokohoma Med Bull 12: 4–22
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Morris, G., Smith, D., Patel, H. et al. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy. Br J Cancer 82, 1764–1771 (2000). https://doi.org/10.1054/bjoc.2000.1148
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1148
Keywords
This article is cited by
-
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy
BMC Cancer (2016)
-
Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose
Journal of Neuro-Oncology (2008)
-
Boron neutron capture therapy (BNCT) for the treatment of spontaneous nasal planum squamous cell carcinoma in felines
Radiation and Environmental Biophysics (2008)
-
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease
Journal of Neuro-oncology (2003)